Ancient human DNA hints at why multiple sclerosis affects so many northern Europeans today

Ancient human DNA hints at why multiple sclerosis affects so many northern Europeans today

WASHINGTON (AP) — Ancient DNA helps explain why northern Europeans have a higher risk of multiple sclerosis than other ancestries: It’s a genetic legacy of horseback-riding cattle herders who swept into the region about 5,000 years ago. The findings come from a huge project to compare modern DNA with that culled from ancient humans’ teeth … Read more

Low-fat diets may reduce fatigue among multiple sclerosis patients, experts flag

Low-fat diets may reduce fatigue among multiple sclerosis patients, experts flag

13 Nov 2023 — Reducing calorie intake may alleviate fatigue in people battling multiple sclerosis (MS), recent research suggests. The findings add additional weight to previous studies, highlighting the importance of reducing fat intake to improve fatigue among people with the condition. “Fatigue is very disabling for these patients,” says senior author Vijayshree Yadav, professor … Read more

Late-Breaking Data for Genentech’s BTK Inhibitor Fenebrutinib Show Brain Penetration and Significant Reduction in Lesions in Patients With Relapsing Multiple Sclerosis | Business & Finance

Late-Breaking Data for Genentech’s BTK Inhibitor Fenebrutinib Show Brain Penetration and Significant Reduction in Lesions in Patients With Relapsing Multiple Sclerosis | Business & Finance

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Oct 13, 2023– Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces brain lesions in people with relapsing multiple sclerosis (RMS), with a consistent safety profile to other … Read more

AI-powered eye scans could revolutionize early detection of Parkinson’s

AI-powered eye scans could revolutionize early detection of Parkinson’s

Markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation have been identified by a UCL and Moorfields Eye Hospital research team. This is the first time anyone has shown these findings several years before diagnosis, and these results were made possible by the largest study to date … Read more